Understanding dendritic cells and their role in cutaneous carcinoma and cancer immunotherapy

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Yanofsky, Valerie R ^a   Mitsui, Hiroshi ^b   Felsen, Diane ^c   Carucci, John A ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIBROMO 3 CHLOROPROPANE; ALPHA INTERFERON; ANTIGEN; CD14 ANTIGEN; CD141 ANTIGEN; CD1C ANTIGEN; CD200 RECEPTOR; DENDRITIC CELL VACCINE; GELATINASE B; GLYCOPROTEIN P 15095; IMIQUIMOD; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 22; INTERLEUKIN 6; LANGERIN; PERFORIN; STROMELYSIN 3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN C; CANCER VACCINE;

ACTINIC KERATOSIS; ALOPECIA AREATA; BASAL CELL CARCINOMA; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONDYLOMA ACUMINATUM; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; LANGERHANS CELL; MEMORY T LYMPHOCYTE; MYELOID DERIVED DERMAL DENDRITIC CELL; NATURAL KILLER CELL; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SKIN CARCINOMA; TUMOR MICROENVIRONMENT; VACCINATION; VERRUCA VULGARIS; ADOPTIVE IMMUNOTHERAPY; ANIMAL; CARCINOMA; CELL DIFFERENTIATION; CELL LINEAGE; IMMUNOLOGY; METHODOLOGY; SKIN; SKIN TUMOR; TRANSPLANTATION;

ANIMALS; CANCER VACCINES; CARCINOMA; CELL DIFFERENTIATION; CELL LINEAGE; DENDRITIC CELLS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; SKIN; SKIN NEOPLASMS;

MLCS; MLOWN;

EID: 84876568228     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/624123     Document Type: Review

References (112)

1. Steinman R. M., Banchereau J., Taking dendritic cells into medicine. Nature 2007 449 7161 419 426 2-s2.0-34848837386 10.1038/nature06175 (Pubitemid 47509552)
2. Steinman R. M., Cohn Z. A., Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. Journal of Immunology 1973 137 5 1142 1162 2-s2.0-39049185232
3. Banchereau J., Steinman R. M., Dendritic cells and the control of immunity. Nature 1998 392 6673 245 252 2-s2.0-0032546352 10.1038/32588 (Pubitemid 28155090)
4. Granucci F., Zanoni I., Ricciardi-Castagnoli P., Central role of dendritic cells in the regulation and deregulation of immune responses. Cellular and Molecular Life Sciences 2008 65 11 1683 1697 2-s2.0-44749085530 10.1007/s00018-008-8009-2
5. Figdor C. G., De Vries I. J. M., Lesterhuis W. J., Melief C. J. M., Dendritic cell immunotherapy: mapping the way. Nature Medicine 2004 10 5 475 480 2-s2.0-2442647551 10.1038/nm1039 (Pubitemid 38667904)
6. Heath W. R., Carbone F. R., Cross-presentation, dendritic cells, tolerance and immunity. Annual Review of Immunology 2001 19 47 64 2-s2.0-0035059416 10.1146/annurev.immunol.19.1.47 (Pubitemid 32368029)
7. Palucka K., Banchereau J., Cancer immunotherapy via dendritic cells. Nature Reviews Cancer 2012 12 4 265 277 10.1038/nrc3258
8. + dendritic cells. The Journal of Experimental Medicine 2011 208 10 2005 2016 10.1084/jem.20101159
9. Schuler G., Dendritic cells in cancer immunotherapy. European Journal of Immunology 2010 40 8 2123 2130 2-s2.0-77956122616 10.1002/eji.201040630
10. Valladeau J., Saeland S., Cutaneous dendritic cells. Seminars in Immunology 2005 17 4 273 283 2-s2.0-22144490866 10.1016/j.smim.2005.05.009 (Pubitemid 40984021)
11. Van Brussel I., Berneman Z. N., Cools N., Optimizing dendritic cell-based immunotherapy: tackling the complexity of different arms of the immune system. Mediators of Inflammation 2012 2012 14 690643 10.1155/2012/690643
12. Mogensen T. H., Pathogen recognition and inflammatory signaling in innate immune defenses. Clinical Microbiology Reviews 2009 22 2 240 273 2-s2.0-66449088641 10.1128/CMR.00046-08
13. Trombetta E. S., Mellman I., Cell biology of antigen processing in vitro and in vivo. Annual Review of Immunology 2005 23 975 1028 2-s2.0-17644370329 10.1146/annurev.immunol.22.012703.104538 (Pubitemid 40563191)
14. Caux C., Massacrier C., Vanbervliet B., Dubois B., Van Kooten C., Durand I., Banchereau J., Activation of human dendritic cells through CD40 cross-linking. Journal of Experimental Medicine 1994 180 4 1263 1272 2-s2.0-0028033310 (Pubitemid 24289600)
15. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y. J., Pulendran B., Palucka K., Immunobiology of dendritic cells. Annual Review of Immunology 2000 18 767 811 2-s2.0-0034041033 10.1146/annurev.immunol.18.1.767 (Pubitemid 30365397)
16. Palucka K., Banchereau J., How dendritic cells and microbes interact to elicit or subvert protective immune responses. Current Opinion in Immunology 2002 14 4 420 431 2-s2.0-0036668239 10.1016/S0952-7915(02)00365-5 (Pubitemid 34671243)
17. Ueno H., Schmitt N., Klechevsky E., Pedroza-Gonzalez A., Matsui T., Zurawski G., Oh S., Fay J., Pascual V., Banchereau J., Palucka K., Harnessing human dendritic cell subsets for medicine. Immunological Reviews 2010 234 1 199 212 2-s2.0-77349093500 10.1111/j.0105-2896.2009.00884.x
18. Chu C. C., Di Meglio P., Nestle F. O., Harnessing dendritic cells in inflammatory skin diseases. Seminars in Immunology 2011 23 1 28 41 2-s2.0-79952438687 10.1016/j.smim.2011.01.006
19. Zaba L. C., Krueger J. G., Lowes M. A., Resident and " inflammatory" dendritic cells in human skin. Journal of Investigative Dermatology 2009 129 2 302 308 2-s2.0-58549114666 10.1038/jid.2008.225
20. + dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation. The Journal of Experimental Medicine 2012 209 5 935 945 10.1084/jem.20112583
21. Narbutt J., Lesiak A., Sysa-Jedrzejowska A., Smolewski P., Robak T., Zalewska A., The number and distribution of blood dendritic cells in the epidermis and dermis of healthy human subject. Folia Histochemica et Cytobiologica 2006 44 1 61 63 2-s2.0-32444437858 (Pubitemid 43224829)
22. Romani N., Holzmann S., Tripp C. H., Koch F., Stoitzner P., Langerhans cells-dendritic cells of the epidermis. APMIS 2003 111 7-8 725 740 2-s2.0-0141630428 10.1034/j.1600-0463.2003.11107805.x (Pubitemid 37130020)
23. Romani N., Clausen B. E., Stoitzner P., Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. Immunological Reviews 2010 234 1 120 141 2-s2.0-77349112874 10.1111/j.0105-2896.2009.00886.x
24. Mc Dermott R., Ziylan U., Spehner D., Bausinger H., Lipsker D., Mommaas M., Cazenave J. P., Raposo G., Goud B., De la Salle H., Salamero J., Hanau D., Birbeck granules are subdomains of endosomal recycling compartment in human epidermal Langerhans cells, which form where Langerin accumulates. Molecular Biology of the Cell 2002 13 1 317 335 2-s2.0-3142525748 10.1091/mbc.01-06-0300 (Pubitemid 34106078)
25. + cells differentiate into Langerhans cells. Nature Immunology 2001 2 12 1151 1158 2-s2.0-0035202722 10.1038/ni731 (Pubitemid 33130150)
26. Seré K., Baek J. H., Ober-Blöbaum J., Two distinct types of Langerhans cells populate the skin during steady state and inflammation. Immunity 2012 37 5 905 916 10.1016/j.immuni.2012.07.019
27. Banchereau J., Klechevsky E., Schmitt N., Morita R., Palucka K., Ueno H., Harnessing human dendritic cell subsets to design novel vaccines. Annals of the New York Academy of Sciences 2009 1174 24 32 2-s2.0-70350474676 10.1111/j.1749-6632.2009.04999.x
28. + DCs controls CTL priming. Blood 2012 119 24 5742 5749 10.1182/blood-2011-08- 371245
29. Wolchok J. D., Peptide-loaded Langerhans cells, despite increased IL15 secretion and T-cell activation in vitro, elicit antitumor T-cell responses comparable to peptide-loaded monocyte-derived dendritic cells in vivo. Clinical Cancer Research 2011 17 11 3851 2-s2.0-79957898586 10.1158/1078-0432.CCR-11-0931
30. + dermal dendritic cells. Immunity 2008 29 3 497 510 2-s2.0-51349093240 10.1016/j.immuni.2008.07.013
31. + T cells lacking IL-17 production. Proceedings of the National Academy of Sciences of the United States of America 2009 106 51 21795 21800 2-s2.0-76049091500 10.1073/pnas.0911472106
32. Fujita H., Suárez-Fariñas M., Mitsui H., Langerhans cells from human cutaneous squamous cell carcinoma induce strong type 1 immunity. Journal of Investigative Dermatology 2012 132 6 1645 1655 10.1038/jid.2012.34
33. + macrophages. Journal of Clinical Investigation 2007 117 9 2517 2525 2-s2.0-34848816502 10.1172/JCI32282 (Pubitemid 47494353)
34. Nestle F. O., Zheng X. G., Thompson C. B., Turka L. A., Nickoloff B. J., Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. Journal of Immunology 1993 151 11 6535 6545 2-s2.0-0027432320 (Pubitemid 23340400)
35. + antigen-presenting cells in human dermis respond rapidly to CCR7 ligands. Journal of Immunology 2006 176 10 5730 5734 2-s2.0-33646467930
36. + hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte- macrophage colony-stimulating factor plus tumor necrosis factor α: II. Functional analysis. Blood 1997 90 4 1458 1470 2-s2.0-0030761725 (Pubitemid 27355417)
37. Chtanova T., Tangye S. G., Newton R., Frank N., Hodge M. R., Rolph M. S., Mackay C. R., T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. Journal of Immunology 2004 173 1 68 78 2-s2.0-2942755979 (Pubitemid 38797327)
38. Bluth M. J., Zaba L. C., Moussai D., Suárez-Farĩas M., Kaporis H., Fan L., Pierson K. C., White T. R., Pitts-Kiefer A., Fuentes-Duculan J., Guttman-Yassky E., Krueger J. G., Lowes M. A., Carucci J. A., Myeloid dendritic cells from human cutaneous squamous cell carcinoma are poor stimulators of T-cell proliferation. Journal of Investigative Dermatology 2009 129 10 2451 2462 2-s2.0-70349087826 10.1038/jid.2009.96
39. + mRNA expression and induces Th2 dominance in the microenvironment of cutaneous squamous cell carcinoma in organ transplant recipients. Journal of Immunotherapy 2010 33 5 538 546 2-s2.0-77952089110 10.1097/CJI.0b013e3181cc2615
40. + regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. European Journal of Immunology 2000 30 6 1538 1543 10.1002/1521- 4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X (Pubitemid 30342794)
41. Bluth M. J., Regulatory T cells are associated with the human cutaneous SCC microenvironment and suppress activation of naive T cells. Journal of Investigative Dermatology 2010 130 S58 S58
42. Corcoran L., Ferrero I., Vremec D., Lucas K., Waithman J., O'Keeffe M., Wu L., Wilson A., Shortman K., The lymphoid past of mouse plasmacytoid cells and thymic dendritic cells. Journal of Immunology 2003 170 10 4926 4932 2-s2.0-0037988844 (Pubitemid 36554721)
43. Cella M., Jarrossay D., Faccheth F., Alebardi O., Nakajima H., Lanzavecchia A., Colonna M., Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nature Medicine 1999 5 8 919 923 2-s2.0-0032773794 10.1038/11360 (Pubitemid 29372419)
44. Kadowaki N., Ho S., Antonenko S., De Waal Malefyt R., Kastelein R. A., Bazan F., Liu Y. J., Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. Journal of Experimental Medicine 2001 194 6 863 869 2-s2.0-0035903288 10.1084/jem.194.6.863 (Pubitemid 32983021)
45. Di Pucchio T., Chatterjee B., Smed-Sörensen A., Clayton S., Palazzo A., Montes M., Xue Y., Mellman I., Banchereau J., Connolly J. E., Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I. Nature Immunology 2008 9 5 551 557 2-s2.0-42449125194 10.1038/ni.1602 (Pubitemid 351560524)
46. Jego G., Palucka A. K., Blanck J. P., Chalouni C., Pascual V., Banchereau J., Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 2003 19 2 225 234 2-s2.0-0041429619 10.1016/S1074-7613(03)00208-5 (Pubitemid 37011337)
47. Urosevic M., Dummer R., Conrad C., Beyeler M., Laine E., Burg G., Gilliet M., Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment. Journal of the National Cancer Institute 2005 97 15 1143 1153 2-s2.0-23244432171 10.1093/jnci/dji207 (Pubitemid 41511214)
48. + nonlymphoid dendritic cells. Immunity 2012 37 1 60 73 10.1016/j.immuni.2012.04.012
49. + dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. Journal of Experimental Medicine 2010 207 6 1247 1260 2-s2.0-77953502765 10.1084/jem.20092140
50. Chomarat P., Banchereau J., Davoust J., Palucka A. K., IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nature Immunology 2000 1 6 510 514 2-s2.0-0034577943
51. Steinbrink K., Wölfl M., Jonuleit H., Knop J., Enk A. H., Induction of tolerance by IL-10-treated dendritic cells. Journal of Immunology 1997 159 10 4772 4780 2-s2.0-0031573204 (Pubitemid 127471012)
52. + T cells that facilitate tumor development. Journal of Experimental Medicine 2007 204 5 1037 1047 2-s2.0-34249000341 10.1084/jem.20061120 (Pubitemid 46798148)
53. Hiltbold E. M., Vlad A. M., Ciborowski P., Watkins S. C., Finn O. J., The mechanism of unresponsiveness to circulating tumor antigen MUC1 is a block in intracellular sorting and processing by dendritic cells. Journal of Immunology 2000 165 7 3730 3741 2-s2.0-0034292388 (Pubitemid 32057279)
54. Chao M. P., Alizadeh A. A., Tang C., Myklebust J. H., Varghese B., Gill S., Jan M., Cha A. C., Chan C. K., Tan B. T., Park C. Y., Zhao F., Kohrt H. E., Malumbres R., Briones J., Gascoyne R. D., Lossos I. S., Levy R., Weissman I. L., Majeti R., Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-hodgkin lymphoma. Cell 2010 142 5 699 713 2-s2.0-77956150056 10.1016/j.cell.2010.07.044
55. Galan A., Ko C. J., Langerhans cells in squamous cell carcinoma vs. pseudoepitheliomatous hyperplasia of the skin. Journal of Cutaneous Pathology 2007 34 12 950 952 2-s2.0-36248979200 10.1111/j.1600-0560.2007.00741.x (Pubitemid 350131999)
56. Nestle F. O., Burg G., Fäh J., Wrone-Smith T., Nickoloff B. J., Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen- presenting cells. American Journal of Pathology 1997 150 2 641 651 2-s2.0-0031024123 (Pubitemid 27073791)
57. Huang F. P., Niedbala W., Wei X. Q., Xu D., Feng G. J., Robinson J. H., Lam C., Liew F. Y., Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages. European Journal of Immunology 1998 28 12 4062 4070 2-s2.0-0031795118 (Pubitemid 28558636)
58. Belkin D. A., Mitsui H., Wang C. Q., CD200 upregulation in vascular endothelium surrounding cutaneous squamous cell carcinoma. Archives of Dermatology 2012 149 2 1 9 10.1001/jamadermatol.2013.1609
59. Pettersen J. S., Fuentes-Duculan J., Suárez-Farĩas M., Pierson K. C., Pitts-Kiefer A., Fan L., Belkin D. A., Wang C. Q. F., Bhuvanendran S., Johnson-Huang L. M., Bluth M. J., Krueger J. G., Lowes M. A., Carucci J. A., Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated. Journal of Investigative Dermatology 2011 131 6 1322 1330 2-s2.0-79955983027 10.1038/jid.2011.9
60. Fadok V. A., Bratton D. L., Konowal A., Freed P. W., Westcott J. Y., Henson P. M., Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF- β PGE2, and PAF. Journal of Clinical Investigation 1998 101 4 890 898 2-s2.0-0032519925 (Pubitemid 28096086)
61. Lin E. Y., Pollard J. W., Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Research 2007 67 11 5064 5066 2-s2.0-34347226359 10.1158/0008-5472.CAN-07-0912 (Pubitemid 46997238)
62. Moussai D., Mitsui H., Pettersen J. S., Pierson K. C., Shah K. R., Suárez-Farĩas M., Cardinale I. R., Bluth M. J., Krueger J. G., Carucci J. A., The human cutaneous squamous cell carcinoma microenvironment is characterized by increased lymphatic density and enhanced expression of macrophage-derived VEGF-C. Journal of Investigative Dermatology 2011 131 1 229 236 2-s2.0-78650294235 10.1038/jid.2010.266
63. Takahara M., Chen S., Kido M., Takeuchi S., Uchi H., Tu Y., Moroi Y., Furue M., Stromal CD10 expression, as well as increased dermal macrophages and decreased Langerhans cells, are associated with malignant transformation of keratinocytes. Journal of Cutaneous Pathology 2009 36 6 668 674 2-s2.0-65949102288 10.1111/j.1600-0560.2008.01139.x
64. Lucas A. D., Halliday G. M., Progressor but not regressor skin tumours inhibit Langerhans' cell migration from epidermis to local lymph nodes. Immunology 1999 97 1 130 137 2-s2.0-0032956922 10.1046/j.1365-2567.1999.00751.x (Pubitemid 29217270)
65. van de Ven R., van den Hout M. F. C. M., Lindenberg J. J., Characterization of four conventional dendritic cell subsets in human skin-draining lymph nodes in relation to T-cell activation. Blood 2011 118 9 2502 2510 10.1182/blood-2011-03-344838
66. Mittelbrunn M., Tejedor R., De La Fuente H., García-López M. A., Ursa Á.., Peñas P. F., García-Díez A., Alonso-Lebrero J. L., Pivel J. P., González S., Gonzalez-Amaro R., Sánchez-Madrid F., Solar-simulated ultraviolet radiation induces abnormal maturation and defective chemotaxis of dendritic cells. Journal of Investigative Dermatology 2005 125 2 334 342 2-s2.0-24344488465 10.1111/j.0022-202X.2005.23824.x (Pubitemid 41648168)
67. Lewis J., Filler R., Smith D. A., Golubets K., Girardi M., The contribution of Langerhans cells to cutaneous malignancy. Trends in Immunology 2010 31 12 460 466 2-s2.0-78649633740 10.1016/j.it.2010.10.001
68. Modi B. G., Neustadter J., Binda E., Langerhans cells facilitate epithelial DNA damage and squamous cell carcinoma. Science 2012 335 6064 104 108 10.1126/science.1211600
69. Hoeffel G., Ripoche A. C., Matheoud D., Nascimbeni M., Escriou N., Lebon P., Heshmati F., Guillet J. G., Gannagé M., Caillat-Zucman S., Casartelli N., Schwartz O., De la Salle H., Hanau D., Hosmalin A., Marañón C., Antigen crosspresentation by human plasmacytoid dendritic cells. Immunity 2007 27 3 481 492 2-s2.0-34548674705 10.1016/j.immuni.2007.07.021 (Pubitemid 47418679)
70. + T cells despite lower Ag uptake than myeloid dendritic cell subsets. Blood 2013 121 3 459 467 10.1182/blood-2012-06-435644
71. Tel J., Aarntzen E. H., Baba T., Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients. Cancer Research 2013 73 3 1063 1075 10.1158/0008-5472.CAN-12-2583
72. Dudziak D., Kamphorst A. O., Heidkamp G. F., Buchholz V. R., Trumpfheller C., Yamazaki S., Cheong C., Liu K., Lee H. W., Chae G. P., Steinman R. M., Nussenzweig M. C., Differential antigen processing by dendritic cell subsets in vivo. Science 2007 315 5808 107 111 2-s2.0-33846636409 10.1126/science.1136080 (Pubitemid 46196991)
73. + T cell tolerance. Journal of Experimental Medicine 2002 196 12 1627 1638 2-s2.0-0037122011 10.1084/jem.20021598 (Pubitemid 36026474)
74. Stoitzner P., Sparber F., Tripp C. H., Langerhans cells as targets for immunotherapy against skin cancer. Immunology and Cell Biology 2010 88 4 431 437 2-s2.0-77952222437 10.1038/icb.2010.31
75. Holzmann S., Tripp C. H., Schmuth M., Janke K., Koch F., Saeland S., Stoitzner P., Romani N., A model system using tape stripping for characterization of langerhans cell-precursors in vivo. Journal of Investigative Dermatology 2004 122 5 1165 1174 2-s2.0-2442484432 10.1111/j.0022-202X.2004. 22520.x (Pubitemid 38651091)
76. Stoitzner P., Green L. K., Jung J. Y., Price K. M., Tripp C. H., Malissen B., Kissenpfennig A., Hermans I. F., Ronchese F., Tumor immunotherapy by epicutaneous immunization requires Langerhans cells. Journal of Immunology 2008 180 3 1991 1998 2-s2.0-40749154946
77. Yagi H., Hashizume H., Horibe T., Yoshinari Y., Hata M., Ohshima A., Ito T., Takigawa M., Shibaki A., Shimizu H., Seo N., Induction of therapeutically relevant cytotoxic T lymphocytes in humans by percutaneous peptide immunization. Cancer Research 2006 66 20 10136 10144 2-s2.0-33750561918 10.1158/0008-5472. CAN-06-1029 (Pubitemid 44672068)
78. Caux C., Dezutter-Dambuyant C., Schmit D., Banchereau J., GM-CSF and TNF- α cooperate in the generation of dendritic Langerhans cells. Nature 1992 360 6401 258 261 2-s2.0-0026446156 10.1038/360258a0
79. Sallusto F., Lanzavecchia A., Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α Journal of Experimental Medicine 1994 179 4 1109 1118 2-s2.0-0028289244
80. + dendritic cells evoking Th1 and Th17 responses. Journal of Immunology 2007 179 3 1449 1457 2-s2.0-34548618728
81. Mohamadzadeh M., Berard F., Essert G., Chalouni C., Pulendran B., Davoust J., Bridges G., Palucka A. K., Banchereau J., Interleukin 15 skews monocyte differentiation into dendritic cells with features of langerhans cells. Journal of Experimental Medicine 2001 194 7 1013 1019 2-s2.0-0035476477 10.1084/jem.194.7.1013 (Pubitemid 32953269)
82. + hematopoietic progenitors stimulate greater cytolytic T lymphocyte activity in the absence of bioactive IL-12p70, by either single peptide presentation or cross-priming, than do dermal-interstitial or monocyte-derived dendritic cells. Journal of Immunology 2004 173 4 2780 2791 2-s2.0-4043055798 (Pubitemid 39063140)
83. Nestle F. O., Alijagic S., Gilliet M., Sun Y., Grabbe S., Dummer R., Burg G., Schadendorf D., Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nature Medicine 1998 4 3 328 332 2-s2.0-0031941423 10.1038/nm0398-328 (Pubitemid 28144092)
84. + progenitor-derived dendritic cell vaccine. Cancer Research 2001 61 17 6451 6458 2-s2.0-0035417932 (Pubitemid 32783251)
85. Thurner B., Haendle I., Röder C., Dieckmann D., Keikavoussi P., Jonuleit H., Bender A., Maczek C., Schreiner D., Von Den Driesch P., Bröcker E. B., Steinman R. M., Enk A., Kämpgen E., Schuler G., Vaccination with Mage-3A1 peptide-pulsed nature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. Journal of Experimental Medicine 1999 190 11 1669 1678 2-s2.0-0033405438 10.1084/jem.190.11.1669 (Pubitemid 30002348)
86. Schuler-Thurner B., Schultz E. S., Berger T. G., Weinlich G., Ebner S., Woerl P., Bender A., Feuerstein B., Fritsch P. O., Romani N., Schuler G., Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells. Journal of Experimental Medicine 2002 195 10 1279 1288 2-s2.0-0037141023 10.1084/jem.20012100 (Pubitemid 34564330)
87. + T-cell immunity. Journal of Immunotherapy 2006 29 5 545 557 2-s2.0-33748693100 10.1097/01.cji.0000211309.90621.8b (Pubitemid 44395279)
88. Palucka K., Ueno H., Zurawski G., Fay J., Banchereau J., Building on dendritic cell subsets to improve cancer vaccines. Current Opinion in Immunology 2010 22 2 258 263 2-s2.0-77951259112 10.1016/j.coi.2010.02.010
89. De Vries I. J. M., Krooshoop D. J. E. B., Scharenborg N. M., Lesterhuis W. J., Diepstra J. H. S., Van Muijen G. N. P., Strijk S. P., Ruers T. J., Boerman O. C., Oyen W. J. G., Adema G. J., Punt C. J. A., Figdor C. G., Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Research 2003 63 1 12 17 2-s2.0-0037226599 (Pubitemid 36070411)
90. Parry R. V., Chemnitz J. M., Frauwirth K. A., Lanfranco A. R., Braunstein I., Kobayashi S. V., Linsley P. S., Thompson C. B., Riley J. L., CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Molecular and Cellular Biology 2005 25 21 9543 9553 2-s2.0-27144496045 10.1128/MCB.25.21.9543- 9553.2005 (Pubitemid 41507854)
91. + T cell efficacy in vaccination and disease. Nature Medicine 2008 14 6 623 628 2-s2.0-44949154503 10.1038/nm.f.1774 (Pubitemid 351809548)
92. + T cells to differentiate into CTL. European Journal of Immunology 2007 37 6 1678 1690 2-s2.0-34250660558 10.1002/eji.200636329 (Pubitemid 46939501)
93. + T cells. Journal of Immunology 1999 163 7 3597 3604 2-s2.0-0033214475 (Pubitemid 29450879)
94. + dendritic cells. Gene Therapy 2012 19 10 1035 1040 10.1038/gt.2011.177
95. Smits E. L. J. M., Ponsaerts P., Berneman Z. N., Van Tendeloo V. F. I., The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy. Oncologist 2008 13 8 859 875 2-s2.0-50649093779 10.1634/theoncologist.2008-0097
96. Hemmi H., Kaisho T., Takeuchi O., Sato S., Sanjo H., Hoshino K., Horiuchi T., Tomizawa H., Takeda K., Akira S., Small-antiviral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nature Immunology 2002 3 2 196 200 2-s2.0-0036008014 10.1038/ni758 (Pubitemid 34141451)
97. Liu C., Lou Y., Lizée G., Qin H., Liu S., Rabinovich B., Kim G. J., Wang Y. H., Ye Y., Sikora A. G., Overwijk W. W., Liu Y. J., Wang G., Hwu P., Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice. Journal of Clinical Investigation 2008 118 3 1165 1175 2-s2.0-40549143697 10.1172/JCI33583 (Pubitemid 351364623)
98. Drobits B., Holcmann M., Amberg N., Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells. The Journal of Clinical Investigation 2012 122 2 575 585 10.1172/JCI61034
99. Thyrell L., Erickson S., Zhivotovsky B., Pokrovskaja K., Sangfelt O., Castro J., Einhorn S., Grandér D., Mechanisms of interferon- α induced apoptosis in malignant cells. Oncogene 2002 21 8 1251 1262 2-s2.0-0037075172 10.1038/sj/onc/1205179 (Pubitemid 34185242)
100. Papageorgiou A., Dinney C. P. N., McConkey D. J., Interferon- α induces TRAIL expression and cell death via an IRF-1-dependent mechanism in human bladder cancer cells. Cancer Biology and Therapy 2007 6 6 872 879 2-s2.0-40649106576 (Pubitemid 351574976)
101. Stary G., Bangert C., Tauber M., Strohal R., Kopp T., Stingl G., Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells. Journal of Experimental Medicine 2007 204 6 1441 1451 2-s2.0-34250324345 10.1084/jem.20070021 (Pubitemid 46919881)
102. Rechtsteiner G., Warger T., Osterloh P., Schild H., Radsak M. P., Cutting edge: priming of CTL by transcutaneous peptide immunization with imiquimod. Journal of Immunology 2005 174 5 2476 2480 2-s2.0-14044265101 (Pubitemid 40279657)
103. + T cells. Immunology 2002 105 2 204 212 2-s2.0-0036172532 10.1046/j.0019-2805.2001.01357.x (Pubitemid 34146687)
104. Upitis J. A., Krol A., The use of diphenylcyclopropenone in the treatment of recalcitrant warts. Journal of Cutaneous Medicine and Surgery 2002 6 3 214 217 2-s2.0-0036324341 10.1007/s10227-001-0050-9 (Pubitemid 34839929)
105. Sotiriadis D., Patsatsi A., Lazaridou E., Kastanis A., Vakirlis E., Chrysomallis F., Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata. Clinical and Experimental Dermatology 2007 32 1 48 51 2-s2.0-33845803238 10.1111/j.1365-2230.2006.02256.x (Pubitemid 46006366)
106. Ryan C. A., Gerberick G. F., Cruse L. W., Basketter D. A., Lea L., Blaikie L., Dearman R. J., Warbrick E. V., Kimber I., Activity of human contact allergens in the murine local lymph node assay. Contact Dermatitis 2000 43 2 95 102 2-s2.0-0033942851 10.1034/j.1600-0536.2000.043002095.x (Pubitemid 30495201)
107. Wack C., Kirst A., Becker J. C., Lutz W. K., Bröcker E. B., Fischer W. H., Chemoimmunotherapy for melanoma with dacarbazine and 2,4- dinitrochlorobenzene elicits a specific T cell-dependent immune response. Cancer Immunology, Immunotherapy 2002 51 8 431 439 2-s2.0-0036042539 10.1007/s00262-002-0292-4 (Pubitemid 35013650)
108. Damian D. L., Shannon K. F., Saw R. P., Thompson J. F., Topical diphencyprone immunotherapy for cutaneous metastatic melanoma. Australasian Journal of Dermatology 2009 50 4 266 271 2-s2.0-72449145330 10.1111/j.1440-0960. 2009.00556.x
109. von Moos S., Johansen P., Waeckerle-Men Y., The contact sensitizer diphenylcyclopropenone has adjuvant properties in mice and potential application in epicutaneous immunotherapy. Allergy 2012 67 5 638 646 10.1111/j.1398-9995. 2012.02802.x
110. Fong L., Engleman E. G., Dendritic cells in cancer immunotherapy. Annual Review of Immunology 2000 18 245 273 2-s2.0-0034121654 10.1146/annurev.immunol. 18.1.245 (Pubitemid 30365381)
111. Kantoff P. W., Higano C. S., Shore N. D., Berger E. R., Small E. J., Penson D. F., Redfern C. H., Ferrari A. C., Dreicer R., Sims R. B., Xu Y., Frohlich M. W., Schellhammer P. F., Sipuleucel-T immunotherapy for castration-resistant prostate cancer. The New England Journal of Medicine 2010 363 5 411 422 2-s2.0-77955066199 10.1056/NEJMoa1001294
112. Schwartzentruber D. J., Lawson D. H., Richards J. M., Conry R. M., Miller D. M., Treisman J., Gailani F., Riley L., Conlon K., Pockaj B., Kendra K. L., White R. L., Gonzalez R., Kuzel T. M., Curti B., Leming P. D., Whitman E. D., Balkissoon J., Reintgen D. S., Kaufman H., Marincola F. M., Merino M. J., Rosenberg S. A., Choyke P., Vena D., Hwu P., gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma. The New England Journal of Medicine 2011 364 22 2119 2127 2-s2.0-79957831345 10.1056/NEJMoa1012863